Subtopic Deep Dive
Narciclasine Anticancer Activity
Research Guide
What is Narciclasine Anticancer Activity?
Narciclasine is an Amaryllidaceae alkaloid from Narcissus species that exhibits potent anticancer activity by inhibiting ribosome biogenesis and inducing apoptosis in cancer cells.
Researchers focus on narciclasine's mechanisms, including 60S ribosome subunit targeting and protein synthesis inhibition (Fürst, 2016, 94 citations). Total synthesis enables analog evaluation for structure-activity relationships (Hudlický et al., 2002, 182 citations). Over 10 papers detail its antitumor properties and in vivo efficacy.
Why It Matters
Narciclasine targets resistant cancer cells via unique ribosome inhibition, offering alternatives to chemotherapies (Fürst, 2016). Its analogs show promise against leukemia and prostate cancer, guiding clinical translation (McNulty et al., 2009; Hu et al., 2015). Synthesis advances support scalable production for drug development (Hudlický et al., 2002). Evidente and Kornienko (2009) evaluated diverse Amaryllidaceae alkaloids, highlighting narciclasine's selectivity.
Key Research Challenges
Scalable Total Synthesis
Efficient biocatalytic synthesis of narciclasine remains complex due to multiple stereocenters (Hudlický et al., 2002). Yields limit analog screening for improved potency. Optimization requires balancing enzymatic dioxygenation with purification steps.
Selectivity Over Normal Cells
Narciclasine induces apoptosis in cancer but lacks full selectivity against healthy cells (Fürst, 2016). Structure-activity studies identify analogs with better therapeutic indices (Evidente and Kornienko, 2009). In vivo models reveal toxicity challenges for clinical use.
Mechanism Elucidation
Precise ribosome binding and downstream signaling pathways need atomic-level detail (McNulty et al., 2009). Biosynthesis insights aid analog design but remain incomplete (Takos and Rook, 2013). Integrating cryo-EM and proteomics data poses integration hurdles.
Essential Papers
The Biological Activity of Natural Alkaloids against Herbivores, Cancerous Cells and Pathogens
Amin Mahmood Thawabteh, Salma Juma, Mariam Bader et al. · 2019 · Toxins · 315 citations
The growing incidence of microorganisms that resist antimicrobials is a constant concern for the scientific community, while the development of new antimicrobials from new chemical entities has bec...
Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes
Emmanuelle Lautié, Olivier Russo, Pierre Ducrot et al. · 2020 · Frontiers in Pharmacology · 212 citations
The screening and testing of extracts against a variety of pharmacological targets in order to benefit from the immense natural chemical diversity is a concern in many laboratories worldwide. And s...
Total Synthesis and Biological Evaluation of <i>Amaryllidaceae</i> Alkaloids: Narciclasine, <i>e</i><i>nt</i>-7-Deoxypancratistatin, Regioisomer of 7-Deoxypancratistatin, 10b-<i>e</i><i>pi</i>-Deoxypancratistatin, and Truncated Derivatives<sup>1</sup>
Tomáš Hudlický, Uwe Rinner, David González et al. · 2002 · The Journal of Organic Chemistry · 182 citations
Biocatalytic approaches have yielded efficient total syntheses of the major Amaryllidaceae alkaloids, all based on the key enzymatic dioxygenation of suitable aromatic precursors. This paper discus...
Lycorine: A prospective natural lead for anticancer drug discovery
Mridul Roy, Long Liang, Xiaojuan Xiao et al. · 2018 · Biomedicine & Pharmacotherapy · 163 citations
Anticancer evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives
Antonio Evidente, Alexander Kornienko · 2009 · Phytochemistry Reviews · 105 citations
Towards a Molecular Understanding of the Biosynthesis of Amaryllidaceae Alkaloids in Support of Their Expanding Medical Use
Adam M. Takos, Fred Rook · 2013 · International Journal of Molecular Sciences · 102 citations
The alkaloids characteristically produced by the subfamily Amaryllidoideae of the Amaryllidaceae, bulbous plant species that include well know genera such as Narcissus (daffodils) and Galanthus (sn...
Multiple biological functions and pharmacological effects of lycorine
Zhifei Cao, Ping Yang, Quansheng Zhou · 2013 · Science China Chemistry · 101 citations
Reading Guide
Foundational Papers
Start with Hudlický et al. (2002, 182 citations) for total synthesis logic and biological evaluation of narciclasine; follow with Evidente and Kornienko (2009, 105 citations) for broad Amaryllidaceae alkaloid anticancer screening.
Recent Advances
Study Fürst (2016, 94 citations) for antitumor mechanisms; Hu et al. (2015, 76 citations) for prostate cancer metastasis inhibition.
Core Methods
Biocatalytic asymmetric dihydroxylation for synthesis (Hudlický et al., 2002); MTT/cytotoxicity assays and flow cytometry for apoptosis (McNulty et al., 2009); in vivo xenograft models for efficacy (Hu et al., 2015).
How PapersFlow Helps You Research Narciclasine Anticancer Activity
Discover & Search
Research Agent uses searchPapers('narciclasine anticancer mechanisms') to retrieve Fürst (2016), then citationGraph reveals Hudlický et al. (2002) as a high-citation foundational synthesis paper, while findSimilarPapers expands to lycorine analogs and exaSearch uncovers unpublished preprints on analogs.
Analyze & Verify
Analysis Agent applies readPaperContent on Hudlický et al. (2002) to extract synthesis yields, then runPythonAnalysis parses IC50 data across papers into pandas DataFrames for statistical comparison of narciclasine vs. lycorine potencies, with verifyResponse (CoVe) and GRADE grading ensuring apoptosis claims match experimental evidence.
Synthesize & Write
Synthesis Agent detects gaps in selectivity data between narciclasine and pancratistatin analogs, while Writing Agent uses latexEditText to draft SAR tables, latexSyncCitations for 10+ references, and latexCompile to generate a review manuscript with exportMermaid diagrams of ribosome inhibition pathways.
Use Cases
"Compare IC50 values of narciclasine analogs from synthesis papers using Python stats"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation, matplotlib potency plots) → researcher gets CSV of normalized IC50s with t-test p-values.
"Draft LaTeX review on narciclasine structure-activity relationships"
Synthesis Agent → gap detection → Writing Agent → latexEditText (SAR section) → latexSyncCitations (Evidente 2009, Hudlický 2002) → latexCompile → researcher gets compiled PDF with figures.
"Find GitHub code for narciclasine docking simulations"
Research Agent → paperExtractUrls (from McNulty 2009 cites) → paperFindGithubRepo → githubRepoInspect → researcher gets AutoDock scripts and docking poses for ribosome models.
Automated Workflows
Deep Research workflow scans 50+ Amaryllidaceae alkaloid papers via searchPapers → citationGraph → structured report ranking narciclasine efficacy by cancer type. DeepScan applies 7-step analysis: readPaperContent on Fürst (2016) → verifyResponse → runPythonAnalysis on dose-responses → GRADE scoring. Theorizer generates hypotheses linking biosynthesis (Takos and Rook, 2013) to optimized anticancer analogs.
Frequently Asked Questions
What defines narciclasine anticancer activity?
Narciclasine inhibits 60S ribosome subunit and protein biosynthesis, inducing apoptosis selectively in cancer cells (Fürst, 2016).
What are key methods for narciclasine research?
Total synthesis uses biocatalytic dioxygenation of aromatics (Hudlický et al., 2002); analogs undergo SAR via cytotoxicity assays (Evidente and Kornienko, 2009).
Which papers establish narciclasine as anticancer?
Hudlický et al. (2002, 182 citations) provides synthesis; Fürst (2016, 94 citations) details mechanisms; McNulty et al. (2009, 101 citations) covers leukemia apoptosis.
What open problems exist in narciclasine research?
Improving synthesis yields, enhancing tumor selectivity, and resolving full ribosome binding structures challenge translation to clinics.
Research Chemical synthesis and alkaloids with AI
PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Code & Data Discovery
Find datasets, code repositories, and computational tools
See how researchers in Chemistry use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Narciclasine Anticancer Activity with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Chemistry researchers
Part of the Chemical synthesis and alkaloids Research Guide